Participants with hepatic impairment must have been on a stable dose of medication or treatment regimen (e.g., no new medications and no changes to current medications within 14 days of screening) and were excluded if they had clinical signs of acute hepatitis, records of biliary obstruction or other causes of hepatic impairment not related to parenchymal disorders or diseases, a history of hepatic encephalopathy Grade 3 or presence of hepatic encephalopathy Grade 2, gastroesophageal varices not managed according to standard of care for patients with cirrhosis or with bleeding within 90 days prior to screening, acute or exacerbation of chronic liver failure or history of liver transplantation
It is highly recommended to conduct a patch test prior to regular application.[4] Users should discontinue use if they experience any signs of allergic reactions, such as redness, hives, or itchiness.[5] Pregnancy & Breastfeeding There is limited data on the safety of GHK-Cu during pregnancy
Store GHK-Cu after reconstitution in the main body of the refrigerator, not the door
Discussion Here, we showed that the intermediate metabolite -KG controls the translation of energy sensor AMPK in human liver and lung cancer cells to maintain cell survival under energy stress
